CMV pneumonia in allogeneic BMT recipients undergoing early treatment or pre-emptive ganciclovir therapy

This publication has 12 references indexed in Scilit:

• Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients: a report from the European Group for Blood and Marrow Transplantation (EBMT)
  Bone Marrow Transplantation, 1998
• Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study
  Blood, 1996
• Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation
  Blood, 1995
• Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis
  Blood, 1994
• A RAPID IMMUNOCYTOCHEMICAL ASSAY FOR CMV DETECTION IN PERIPHERAL BLOOD OF ORGAN-TRANSPLANTED PATIENTS IN CLINICAL PRACTICE
  Transplantation, 1993
• Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation
  Blood, 1992
• Early Treatment with Ganciclovir to Prevent Cytomegalovirus Disease after Allogeneic Bone Marrow Transplantation
  New England Journal of Medicine, 1991
• Treatment of Cytomegalovirus Pneumonia with Ganciclovir and Intravenous Cytomegalovirus Immunoglobulin in Patients with Bone Marrow Transplants
  Annals of Internal Medicine, 1988
• Progress in the Treatment of Cytomegalovirus Pneumonia
  Annals of Internal Medicine, 1988
• Activity of 9-[2-Hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the Treatment of Cytomegalovirus Pneumonia
  Annals of Internal Medicine, 1985